Assays

Characterization and testing of biopharmaceuticals: Using our expert's insight into a biologic's structure, physicochemical properties, potency, and impurity profile, we help you meet your development milestones.

A range of expertise is available, including assessment of structure...

Brightlabs has in-house validated methods for the analysis of elemental impurities in accordance to ICH-Q3D. Brightlabs has a unique approach for ICHQ3D, which guarantees quick turnaround times at reduced cost

Since 2018 Brightlabs possesses an opium exemption from the BMC (Bureau for Medicinal Cannabis), for the analysis of cannabis and related products. The combination of this opium exemption, combined with our GMP accreditation, makes Brightlabs an important partner for the analysis of cannabis and related ma...

For 500x12 µl reactions (20x): QIAGEN Cell and Gene Therapy assay for GFP to be used with the QIAcuity dPCR system.

Features
• A broad offering of ten different wet-lab validated dPCR CGT assays • Assays with different fluorophore choices allow multiplexing to sustain vector integrity • An e...

The dPCR Microbial DNA Detection Assays are designed to test for the presence of bacterial, fungal, parasitic, viral, antibiotic resistance or virulence factor genes using digital PCR. The assays can be run on the QIAcuity® in about two hours with minimal hands-on time. The assays target over 680 bacterial...

Compound screening against a drug target is a vital step in early stage drug discovery. Biortus has an extensive collection of testing equipment that allows development of many kinds of biochemical assays, biophysical assays, and cell-based assays. Key assays include SPR, Kinase, ADP-Glo, TR-FRET, FP, Cali...